Early Versus Late Administration of Long-Acting Insulin in Adult Diabetic Ketoacidosis.

Document Type

Article

Publication Date

9-9-2024

Publication Title

The Annals of pharmacotherapy

Abstract

BACKGROUND: Evidence is inconclusive if early administration of subcutaneous (SQ) long-acting insulin (LAI) in management of diabetic ketoacidosis (DKA) improves outcomes.

OBJECTIVE: This study compares early versus late administration of SQ LAI in time to DKA resolution.

METHODS: This single-center, retrospective study included patients with DKA who received ≥12 hours of continuous intravenous insulin (CIVI) with LAI overlap. Patients were compared based on LAI administration time to CIVI initiation: Early (<12 >hours) versus Late (≥12 hours). The DKA resolution is defined as blood glucose < 200 mg/dL and 2 of the following: anion gap < 12 mEq/L, pH > 7.35, or serum carbon dioxide >15 mEq/L. Outcomes included time to DKA resolution, length of stay (LOS), CIVI duration, and adverse events.

RESULTS: A total of 27 patients were included in each group. Baseline characteristics were similar between both groups. There was no difference in time to DKA resolution, Early = 17.6 (13.9-26.8) hours versus Late = 19.2 (17.1-32.1) hours,

CONCLUSION AND RELEVANCE: Administration of SQ LAI < 12 hours did not decrease time to DKA resolution or LOS. Patients in the Early group had received a lower dose of LAI, shorter duration of CIVI infusion, and required less IV fluids within 36 hours of admission. This study supports the need for further research to determine the potential benefits of administering SQ insulin early in managing DKA.

Last Page

10600280241278371

DOI

10.1177/10600280241278371

ISSN

1542-6270

PubMed ID

39250171

Link to Full Text

Share

COinS